1 |
Raab MS,Podar K,Breitkreutz I, et al. Multiple mye-loma[J]. Lancet, 2009, 374(9686): 324-339.
|
2 |
Mahindra A,Hideshima T,Anderson KC. Multiple my-eloma: biology of the disease[J]. Blood Rev, 2010 (24 Suppl 1): S5-S11.
|
3 |
Robak T,Korycka A,Kasznicki M, et al. Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications[J]. Curr Cancer Drug Targets, 2005, 5(6): 421-444.
|
4 |
廖明徽,廖冰费. 甲基转移酶抑制剂作为肿瘤诱导分化疗法的优良分化帮助剂[J]. 中国肿瘤, 2002, 11(3):166-168.
|
5 |
叶宝东,沈一平,周郁鸿, 等. 尿多酸肽(CDA-2)诱导多发性骨髓瘤细胞RPMI8226凋亡的实验研究[J]. 浙江中医药大学学报, 2010, 34(5):650-651, 657.
|
6 |
Tsirakis G,Pappa CA,Kaparou M, et al. The relation-ship between soluble receptor of interleukin-6 with angiogenic cytokines and proliferation markers in multiple myeloma[J]. Tumour Biol, 2013, 34(2): 859-864.
|
7 |
郑鸿,陶莉,肖谜. CDA-Ⅱ联合化疗治疗晚期复治非小细胞肺癌的临床观察[J]. 中国癌症杂志, 2012, 22(11):873-875.
|
8 |
孟志强,黄雯霞,王振玖. 尿多酸肽治疗乳腺癌Ⅱ期临床研究[J]. 中国肿瘤, 2002, 11(2):113-114.
|
9 |
宋辉,杨涛,郭媛媛, 等. 尿多酸肽对慢性髓性白血病K562细胞增殖及凋亡的影响[J]. 实用临床医药杂志, 2013, 17(14):1-4.
|
10 |
黄健,杨敏,金洁. 尿多酸肽对骨髓增生异常综合征PTEN基因甲基化的影响及相关机制研究[J]. 中华血液学杂志, 2013, 34(7):600-605.
|
11 |
蔡安民,万海英,周宏, 等. 尿多酸肽对急性早幼粒细胞白血病细胞系凋亡作用的实验研究[J]. 同济大学学报(医学版), 2010, 31(2):38-43.
|
12 |
叶宝东,邵科钉,陈丹, 等. 尿多酸肽抑制多发性骨髓瘤细胞株RPIMI8226增殖及其机制研究[J]. 中国现代应用药学, 2013, 30(11):1161-1165.
|
13 |
Fernandes-Alnemri T,Litwack G,Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme[J]. J Biol Chem, 1994, 269(49): 30761-30764.
|
14 |
李雪娇,陈俊杰,王磊, 等. 乌司他丁对脓毒症大鼠肝脏保护作用及其抗肝细胞凋亡机制的研究[J/CD]. 中华危重症医学杂志(电子版), 2017, 10(2):76-81.
|
15 |
Millet P,Lages CS,Haik S, et al. Amyloid-beta peptide triggers Fas-independent apoptosis and differentiation of neural progenitor cells[J]. Neurobiol Dis, 2005, 19(1-2): 57-65.
|